A Short Commentary on Emerging Evidence on Monkeypox: Resurgence, Global Burden, Molecular Insights, Genomics and Possible Management
*Corresponding Author: Kow-Tong Chen, Department of Public Health, National Cheng Kung University, Tainan, Taiwan, Email: ktchen@mail.ncku.edu.twReceived Date: May 15, 2023 / Published Date: Oct 31, 2023
Citation: Huang CY, Su SB, Chen KT (2023) A Short Commentary on Emerging Evidence on Monkeypox: Resurgence, Global Burden, Molecular Insights, Genomics and Possible Management. J Infect Dis Ther 11: 554.
Copyright: © 2023 Huang CY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Human monkeypox is an emerging zoonotic disease. The etiology of this disease is a double-stranded DNA virus classified into the genus Orthopoxvirus and the family Poxviridae. In 2022, outbreaks of monkeypox virus infection occurred in several nonendemic countries and caused a potential threat to humans. It is urgent to take immediate action to control and prevent the outbreak of the monkeypox virus infection. This paper highlights the need for further research on molecular mechanisms of pathophysiological reactions and control strategies for monkeypox disease are crucial.